Trial
NCT02713061
A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Takeda
Collaborators
—
Condition
Influenza Prevention
Intervention
TAK-850
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-25